Antibiotics for the prophylaxis of bacterial endocarditis in dentistry
The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Infective endocarditis is a severe infection arising in the lining of the chambers of the heart with a high mortality rate.Many dental procedures cause bacteraemia and it was believed that this may lead to bacterial endocarditis (BE) in a few people. Guidelines in many countries have recommended that prior to invasive dental procedures antibiotics are administered to people at high risk of endocarditis. However, recent guidance by the National Institute for Health and Care Excellence (NICE) in England and Wales has recommended that antibiotics are not required. OBJECTIVES: To determine whether prophylactic antibiotic administration, compared to no such administration or placebo, before invasive dental procedures in people at risk or at high risk of bacterial endocarditis influences mortality, serious illness or the incidence of endocarditis. SEARCH METHODS: The following electronic databases were searched: the Cochrane Oral Health Group's Trials Register (to 21 January 2013), the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2012, Issue 12), MEDLINE via OVID (1946 to 21 January 2013) and EMBASE via OVID (1980 to 21 January 2013). We searched for ongoing trials in the US National Institutes of Health Trials Register (http://clinicaltrials.gov) and the metaRegister of Controlled Trials (http://www.controlled-trials.com/mrct/). No restrictions were placed on the language or date of publication when searching the electronic databases. SELECTION CRITERIA: Due to the low incidence of BE it was anticipated that few if any trials would be located. For this reason, cohort and case-control studies were included where suitably matched control or comparison groups had been studied. The intervention was the administration of antibiotic, compared to no such administration, before a dental procedure in people with an increased risk of BE. Cohort studies would need to follow those individuals at increased risk and assess outcomes following any invasive dental procedures, grouping by whether prophylaxis was received or not. Included case-control studies would need to match people who had developed endocarditis (and who were known to be at increased risk before undergoing an invasive dental procedure preceding the onset of endocarditis) with those at similar risk but who had not developed endocarditis. Outcomes of interest were mortality or serious adverse events requiring hospital admission; development of endocarditis following any dental procedure in a defined time period; development of endocarditis due to other non-dental causes; any recorded adverse events to the antibiotics; and cost implications of the antibiotic provision for the care of those patients who developed endocarditis. DATA COLLECTION AND ANALYSIS: Two review authors independently selected studies for inclusion then assessed risk of bias and extracted data from the included study. MAIN RESULTS: No randomised controlled trials (RCTs), controlled clinical trials (CCTs) or cohort studies were included. One case-control study met the inclusion criteria. It collected all the cases of endocarditis in the Netherlands over two years, finding a total of 24 people who developed endocarditis within 180 days of an invasive dental procedure, definitely requiring prophylaxis according to current guidelines, and who were at increased risk of endocarditis due to a pre-existing cardiac problem. This study included participants who died because of the endocarditis (using proxies). Controls attended local cardiology outpatient clinics for similar cardiac problems, had undergone an invasive dental procedure within the past 180 days, and were matched by age with the cases. No significant effect of penicillin prophylaxis on the incidence of endocarditis could be seen. No data were found on other outcomes. AUTHORS' CONCLUSIONS: There remains no evidence about whether antibiotic prophylaxis is effective or ineffective against bacterial endocarditis in people at risk who are about to undergo an invasive dental procedure. It is not clear whether the potential harms and costs of antibiotic administration outweigh any beneficial effect. Ethically, practitioners need to discuss the potential benefits and harms of antibiotic prophylaxis with their patients before a decision is made about administration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
Statistical Methods for Rates and Proportions.
Everitt, B. S., & Fleiss, J. L. (1981) · Biometrics · doi:10.2307/2530193 · Cited by 8,990
Downs, S. H., & Black, N. (1998) · Journal of Epidemiology and Community Health · doi:10.1136/jech.52.6.377 · Cited by 8,252
Wilson, W., Taubert, K. A., Gewitz, M., Lockhart, P. B., Baddour, L. M., Levison, M., Bolger, A., Cabell, C. H., Takahashi, M., Baltimore, R. S., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.183095 · Cited by 2,814
Pochet, P. (2006) · Griffith Research Online · Cited by 1,550
Prevention of bacterial endocarditis. Recommendations by the American Heart Association
(1997) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1016/s1053-0770(97)90147-6 · Cited by 1,264
Prevention of Bacterial Endocarditis: Recommendations by the American Heart Association
Dajani, A. S. (1997) · JAMA · doi:10.1001/jama.1997.03540460058033 · Cited by 1,042
Changing Profile of Infective Endocarditis<SUBTITLE>Results of a 1-Year Survey in France</SUBTITLE>
Hoen, B. (2002) · JAMA · doi:10.1001/jama.288.1.75 · Cited by 987
Infective Endocarditis: An Analysis Based on Strict Case Definitions
VON REYN, C. F., LEVY, B. S., ARBEIT, R. D., FRIEDLAND, G., & CRUMPACKER, C. S. (1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-4-505 · Cited by 775
Meyler's Side Effects of Drugs
(2016) · Elsevier eBooks · doi:10.1016/c2009-1-62477-1 · Cited by 756
Meyler's Side Effects of Drugs
Breckenridge, A. M. (1976) · BMJ · doi:10.1136/bmj.2.6030.307 · Cited by 691
The Heart, Arteries and Veins.
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-2-276_2 · Cited by 581
Prevention of Bacterial Endocarditis: Recommendations by the American Heart Association
DAJANI, A. S., TAUBERT, K. A., WILSON, W., BOLGER, A. F., BAYER, A., FERRIERI, P., GEWITZ, M. H., SHULMAN, S. T., NOURI, S., NEWBUGER, J. W., et al. (1998) · Survey of Anesthesiology · doi:10.1097/00132586-199804000-00055 · Cited by 568
Dental and Cardiac Risk Factors for Infective Endocarditis: A Population-Based, Case-Control Study
Strom, B. L., Abrutyn, E., Berlin, J. A., Kinman, J. L., Feldman, R. S., Stolley, P. D., Levison, M. E., Korzeniowski, O. M., & Kaye, D. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-10-199811150-00002 · Cited by 462
Gould, F. K. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl121 · Cited by 398
Temporal Trends in Infective Endocarditis in the Context of Prophylaxis Guideline Modifications
Duval, X., Delahaye, F., Alla, F., Tattevin, P., Obadia, J.-F., Le Moing, V., Doco-Lecompte, T., Celard, M., Poyart, C., Strady, C., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.029 · Cited by 383
Roberts, G. J. (1999) · Pediatric Cardiology · doi:10.1007/s002469900477 · Cited by 352
Self-citationEfficacy of antibiotic prophylaxis for prevention of native-valve endocarditis
van der Meer, J. T. M., Michel, M. F., Valkenburg, H. A., van der Meer, J. T. M., van Wijk, W., Thompson, J., & Vandenbroucke, J. P. (1992) · The Lancet · doi:10.1016/0140-6736(92)90207-j · Cited by 349
How important are dental procedures as a cause of infective endocarditis?
Guntheroth, W. G. (1984) · The American Journal of Cardiology · doi:10.1016/s0002-9149(84)80211-8 · Cited by 326
Fritz, R. (1994) · The Path of Least Resistance · doi:10.1016/b978-0-7506-2108-3.50007-1 · Cited by 303
The oral cavity as a reservoir of bacterial pathogens for focal infections
Gendron, R., Grenier, D., & Maheu-Robert, L.-F. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)00391-9 · Cited by 254
Thornhill, M. H., Dayer, M. J., Forde, J. M., Corey, G. R., Chu, V. H., Couper, D. J., & Lockhart, P. B. (2011) · BMJ · doi:10.1136/bmj.d2392 · Cited by 254
Risk Factors for Infective Endocarditis: Oral Hygiene and Nondental Exposures
Strom, B. L., Abrutyn, E., Berlin, J. A., Kinman, J. L., Feldman, R. S., Stolley, P. D., Levison, M. E., Korzeniowski, O. M., & Kaye, D. (2000) · Circulation · doi:10.1161/01.cir.102.23.2842 · Cited by 238
Procedures associated with infective endocarditis in adults
LACASSIN, F., HOEN, B., LEPORT, C., SELTON-SUTY, C., DELAHAYE, F., GOULET, V., ETIENNE, J., & BRIANÇON, S. (1995) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a060855 · Cited by 211
A Controlled Evaluation of the Risk of Bacterial Endocarditis in Persons with Mitral-Valve Prolapse
Clemens, J. D., Horwitz, R. I., Jaffe, C. C., Feinstein, A. R., & Stanton, B. F. (1982) · New England Journal of Medicine · doi:10.1056/nejm198209233071302 · Cited by 209
Netzer, R. O.-M., Zollinger, E., Seiler, C., & Cerny, A. (2000) · Heart · doi:10.1136/heart.84.1.25 · Cited by 187
Imperiale, T. F., & Horwitz, R. I. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90461-l · Cited by 180
Oxford textbook of clinical pharmacology and drug therapy
(1993) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(93)90450-c · Cited by 177
van der Meer, J. T. M. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.9.1869 · Cited by 175
Plasma alkaline phosphatase activity in preterm neonates.
Schilling, R., Haschke, F., Kovarik, J. J., & Woloszczuk, W. (1982) · PubMed · Cited by 161
Wilson, W. R., Gewitz, M. H., Baddour, L. M., Levison, M. E., Takahashi, M., Newburger, J. W., Strom, B. L., Tani, L. Y., Gerber, M. A., Bonow, R. O., et al. (2007) · Cited by 136
Prophylaxis of infective endocarditis: French recommendations 2002
Danchin, N., Duval, X., & Leport, C. (2005) · Heart · doi:10.1136/hrt.2003.033183 · Cited by 123
van der Meer, J. T. M. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400210093015 · Cited by 122
Kaufman, D. W., & Anaphylaxis, T. I. C. S. O. S. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.822 · Cited by 121
Endocarditis prophylaxis for patients with mitral valve prolapse
Bor, D. H., & Himmelstein, D. U. (1984) · The American Journal of Medicine · doi:10.1016/0002-9343(84)90300-0 · Cited by 121
Results of a UK survey of fatal anaphylaxis after oral amoxicillin
Lee, P., & Shanson, D. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm315 · Cited by 104
The long term prognosis of infective endocarditis
Delahaye, F., Écochard, R., de Gévigney, G., Barjhoux, C. E., Malquarti, V., Saradarian, W., & Delaye, J. (1995) · European Heart Journal · doi:10.1093/eurheartj/16.suppl_b.48 · Cited by 93
Effects of changes in management of active infective endocarditis on outcome in a 25-year period
Verheul, H. A., van den Brink, R. B. A., van Vreeland, T., Moulijn, A. C., Düren, D. R., & Dunning, A. J. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90885-g · Cited by 79
Contribution for choosing the optimal prophylaxis of bacterial endocarditis
Horstkotte, D., Rosin, H., Friedrichs, W., & Loogen, F. (1987) · European Heart Journal · doi:10.1093/eurheartj/8.suppl_j.379 · Cited by 75
Epidemiology and antibiotic treatment of infective endocarditis: an update
Hoen, B. (2006) · Heart · doi:10.1136/hrt.2005.072595 · Cited by 68 · cited 1×
“More recently, however, this trend has shifted with nearly half of the cases of endocarditis having no known previous cardiac disease (Duval 2012; Hoen 2002; Hoen 2006).”
BackgroundBacteremias Following Periodontal Scaling in Patients with Healthy Appearing Gingiva
Conner, H. D., Haberman, S., Collings, C. K., & Winford, T. E. (1967) · Journal of Periodontology · doi:10.1902/jop.1967.38.6_part1.466 · Cited by 67
Woodman, A., Vidic, J., Newman, H. N., & Marsh, P. D. (1985) · Journal of Medical Microbiology · doi:10.1099/00222615-19-1-15 · Cited by 51
Al‐Karaawi, Z. M., Lucas, V. S., Gelbier, M. J., & ROBERTS, G. J. (2001) · Heart · doi:10.1136/heart.85.1.66 · Cited by 44
Self-citationInfective endocarditis and dentistry: the legal basis for an association
Martin, M. V., Longman, L., Forde, M., & Butterworth, M. L. (2007) · BDJ · doi:10.1038/bdj.2007.123 · Cited by 28
Controversies in the prophylaxis of infective endocarditis: a cardiological view
Oakley, C. M. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/20.suppl_a.99 · Cited by 27
[Bacterial endocarditis in Morocco].
Bennis, A., Zahraoui, M., Azzouzi, L., Soulami, S., Mehadji, B. A., Tahiri, A., & Chraibi, N. (1995) · PubMed · Cited by 22
Beyond the antibiotic prophylaxis of infective endocarditis: the problem of dental surveillance
Chambers, J. B., Dayer, M., Prendergast, B., Sandoe, J. A. T., Westaby, S., Thornhill, M. H., & on behalf of the British Heart Valve Society (2012) · Heart · doi:10.1136/heartjnl-2012-302965 · Cited by 20
Infective endocarditis in infants and children
Bhat, A. W., Jalal, S., John, V., & Bhat, A. M. (1996) · The Indian Journal of Pediatrics · doi:10.1007/bf02845245 · Cited by 14
Evaluation économique exploratoire de la prophylaxie de l'endocardite infectieuse
Bonhomme, I., Briançon, S., & Fagnani, F. (1992) · Médecine et Maladies Infectieuses · doi:10.1016/s0399-077x(05)80537-2 · Cited by 6
Cited by
Habib, G., Lancellotti, P., Antunes, M. J., Bongiorni, M. G., Casalta, J.-P., Del Zotti, F., Dulgheru, R., El Khoury, G., Erba, P. A., Iung, B., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv319 · Cited by 4,997
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.011 · Cited by 3,339
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,905
Metadata
- Authors
- Glenny, A.-M., Oliver, R., Roberts, G. J., Hooper, L., & Worthington, H. V.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2013-10-09
- Issue
- 10
- Pages
- CD003813-CD003813
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2098014106
- Cited by
- 236
- References
- 49
- FWCI
- 11.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.